Notice: This company has been marked as potentially delisted and may not be actively trading. F-star Therapeutics (FSTX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Astria Therapeutics price target raised to $28 from $26 at OppenheimerNovember 14, 2024 | markets.businessinsider.comLake Street Remains a Buy on Aquestive Therapeutics (AQST)October 25, 2024 | markets.businessinsider.comStarton Therapeutics Announces Successful Feasibility Demonstration of STAR-LLD Using BD Evolve™ On-Body InjectorSeptember 18, 2024 | markets.businessinsider.comBicara Therapeutics Rises 39% in Debut on NasdaqSeptember 15, 2024 | marketwatch.comAnalysts Offer Insights on Healthcare Companies: Poseida Therapeutics (PSTX) and SAGE Therapeutics (SAGE)July 25, 2024 | markets.businessinsider.comBuy Rating for Astria Therapeutics: Promising STAR-0215 Outpaces Competitors with Strategic Trials and Market PotentialMay 10, 2024 | markets.businessinsider.comAstria Therapeutics: Strong Buy Rating on Robust Finances and Promising Clinical TrialsMay 10, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Pliant Therapeutics (PLRX) and Crinetics Pharmaceuticals (CRNX)May 7, 2024 | markets.businessinsider.comAdam22's porn star wife Lena The Plug ADMITS she enjoyed sex with other man MORE than husband'sJuly 20, 2023 | dailymail.co.ukA*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the USJuly 12, 2023 | finance.yahoo.comTwitch star Amouranth reveals she has been diagnosed with 'late stage ovarian failure' at AGE 29 - after 'shrugging off confusing mental and physical symptoms' for MONTHSJuly 11, 2023 | dailymail.co.ukDouglas F. MayoJune 26, 2023 | startribune.comOchre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of DirectorsJune 2, 2023 | finance.yahoo.comF. Murray Abraham apologizes after sexual misconduct allegationsApril 24, 2023 | sfgate.comTrading was temporarily halted for "FSTX" at 07:03 PM with a stated reason of "News pending."March 9, 2023 | marketbeat.cominvoX Pharma Completes Acquisition of F-star Therapeutics, Inc.March 8, 2023 | businesswire.comF-star Therapeutics, Inc.: F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX PharmaMarch 7, 2023 | finanznachrichten.deF-star Therapeutics surges as buyer Sino Biopharma gains CFIUS approvalMarch 7, 2023 | msn.comWhy F-Star Therapeutics Shares Are Moving HigherMarch 7, 2023 | msn.comF-star Therapeutics Shares Rally After Cfius Clears Takeover >FSTXMarch 7, 2023 | marketwatch.comF-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX PharmaMarch 7, 2023 | finance.yahoo.comF-Star Therapeutics Blasts Up as Merger Deal Goes ThroughMarch 7, 2023 | msn.comF-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX PharmaMarch 7, 2023 | finance.yahoo.comF-star Therapeutics surges on report sale to Sino Biopharma close to CFIUS approvalMarch 7, 2023 | msn.comGabelli Funds LLC Buys 23,545 Shares of F-star Therapeutics, Inc. (NASDAQ:FSTX)Gabelli Funds LLC grew its stake in shares of F-star Therapeutics, Inc. (NASDAQ:FSTX - Get Rating) by 13.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 192,373 shares of the company's stock after purchaMarch 2, 2023 | marketbeat.comErgoteles LLC Increases Stake in F-star Therapeutics, Inc. (NASDAQ:FSTX)Ergoteles LLC boosted its stake in shares of F-star Therapeutics, Inc. (NASDAQ:FSTX - Get Rating) by 38.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 148,354 shares of the company's stockFebruary 28, 2023 | marketbeat.comF-star Therapeutics jumps as it extends walk date with buyer to `finalize' CFIUS agreementFebruary 25, 2023 | seekingalpha.comF-star Therapeutics Inc Ordinary SharesFebruary 25, 2023 | morningstar.comF-star Therapeutics jumps as it extends walk date with buyer to `finalize" CFIUS agreementFebruary 23, 2023 | msn.comWhile institutions own 48% of F-star Therapeutics, Inc. (NASDAQ:FSTX), retail investors are its largest shareholders with 49% ownershipFebruary 22, 2023 | finance.yahoo.comInvestors Buy Large Volume of Call Options on F-star Therapeutics (NASDAQ:FSTX)F-star Therapeutics, Inc. (NASDAQ:FSTX - Get Rating) was the recipient of unusually large options trading on Friday. Traders bought 12,457 call options on the stock. This is an increase of 1,432% compared to the average volume of 813 call options.February 17, 2023 | marketbeat.comF-star Therapeutics gains after deal termination date with buyer extended againFebruary 9, 2023 | msn.comF-star Therapeutics gains as buyer Sino Biopharma cancels Shanghai listingFebruary 8, 2023 | msn.comRussell Investments Group Ltd. Grows Stock Holdings in F-star Therapeutics, Inc. (NASDAQ:FSTX)Russell Investments Group Ltd. raised its holdings in shares of F-star Therapeutics, Inc. (NASDAQ:FSTX - Get Rating) by 31.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 490,712 shares of the company's stock after puFebruary 7, 2023 | marketbeat.comF-star Therapeutics up 18% as it extends end date of merger with invoX PharmaFebruary 1, 2023 | msn.comF-star Therapeutics, Inc. (NASDAQ:FSTX) Short Interest Down 14.4% in JanuaryF-star Therapeutics, Inc. (NASDAQ:FSTX - Get Rating) was the target of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 672,700 shares, a decrease of 14.4% from the December 31st total of 785,900 shares. Currently, 3.5% of the shares of the stock are sold short. Based on an average daily volume of 382,600 shares, the short-interest ratio is presently 1.8 days.January 29, 2023 | marketbeat.comF-star Therapeutics, Inc.: invoX Pharma and F-star Therapeutics issue Joint StatementJanuary 26, 2023 | finanznachrichten.deFSTX F-star Therapeutics, Inc.January 26, 2023 | seekingalpha.comF-star Therapeutics partly pares loss as buyer says in active talks with CFIUS (update)January 26, 2023 | msn.comTrading was temporarily halted for "FSTX" at 03:01 PM with a stated reason of "LULD pause."January 26, 2023 | marketbeat.comWhy Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJanuary 26, 2023 | msn.comTrading was temporarily halted for "FSTX" at 10:01 AM with a stated reason of "LULD pause."January 26, 2023 | marketbeat.comTrading was temporarily halted for "FSTX" at 10:01 AM with a stated reason of "LULD pause."January 26, 2023 | marketbeat.comTrading was temporarily halted for "FSTX" at 10:01 AM with a stated reason of "LULD pause."January 26, 2023 | marketbeat.comTrading was temporarily halted for "FSTX" at 10:01 AM with a stated reason of "LULD pause."January 26, 2023 | marketbeat.comJane F. PieriJanuary 23, 2023 | startribune.comStock Traders Purchase High Volume of F-star Therapeutics Put Options (NASDAQ:FSTX)F-star Therapeutics, Inc. (NASDAQ:FSTX - Get Rating) was the target of some unusual options trading activity on Friday. Investors purchased 4,510 put options on the company. This is an increase of 2,133% compared to the average volume of 202 put options.December 30, 2022 | marketbeat.comTrading was temporarily halted for "FSTX" at 07:12 PM with a stated reason of "News pending."December 29, 2022 | marketbeat.comWhy Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day SessionDecember 21, 2022 | msn.comShort Interest in F-star Therapeutics, Inc. (NASDAQ:FSTX) Rises By 64.1%F-star Therapeutics, Inc. (NASDAQ:FSTX - Get Rating) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 354,700 shares, a growth of 64.1% from the November 15th total of 216,200 shares. Approximately 1.9% of the company's stock are sold short. Based on an average daily volume of 200,900 shares, the days-to-cover ratio is presently 1.8 days.December 13, 2022 | marketbeat.com Get F-star Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FSTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast. Click here for the ticker >>> FSTX Media Mentions By Week FSTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FSTX News Sentiment▼0.000.59▲Average Medical News Sentiment FSTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FSTX Articles This Week▼00▲FSTX Articles Average Week Get F-star Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FSTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PHAR News Today MLYS News Today TERN News Today ORIC News Today SVRA News Today PHAT News Today IRWD News Today ANNX News Today ATXS News Today MREO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FSTX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F-star Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share F-star Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FSTX Stock Alerts